Portfolio company
Mindstate
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops designer psychedelic compounds using artificial intelligence to treat mental health conditions such as treatment-resistant post-traumatic stress disorder.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Mindstate Design Labs
This biotechnology company develops custom psychedelic therapeutics using an artificial intelligence platform to treat mental health conditions for patients with various psychiatric disorders.
Mycrodose Therapeutics
This pharmaceutical company develops advanced drug delivery systems for psychedelic and cannabinoid compounds to treat mental health and cognitive degenerative diseases.
ATAI
This biopharmaceutical company develops psychedelic-based treatments and mental health medicines for patients with neurological and psychiatric disorders, such as treatment-resistant depression and anxiety.
Pangea Botanica
This company develops medicines for neurological and mental health disorders using an artificial intelligence platform to discover neuroactive molecules from medicinal plants.
GH Research
This pharmaceutical company develops psychedelic-based therapies for patients suffering from psychiatric and neurological disorders, including treatment-resistant depression.
Psylink
This biotechnology company develops psychedelic therapies using engineered yeast to produce plant and fungi-derived compounds for patients with treatment-resistant mental health disorders.
Helus Pharma
This pharmaceutical company develops serotonergic agonists and psychedelic medicines to treat patients with depression, anxiety and other mental health conditions.
Beckley Psytech
The company develops psychedelic-derived medicines to treat patients with neurological and psychiatric conditions such as treatment-resistant depression and rare headache disorders.
